She Chen

Dr. She Chen

Key Laboratory of Glycoconjugate Research Ministry of Public Health, Department of Biochemistry and Molecular Biology, Shanghai Medical College, Fudan University, Shanghai 200032, China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
PDPingping Dong
Pingping Dong
LMLijie Ma
Lijie Ma
LLLongzi Liu
Longzi Liu
GZGuangxi Zhao
Guangxi Zhao
SZSi Zhang
Si Zhang
She ChenShe Chen
She Chen
Tumor-associated macrophages (TAMs), the most abundant infiltrating immune cells in tumor microenvironment, have distinct functions in hepatocellular carcinoma (HCC) progression. CD68+ TAMs represent multiple polarized immune cells mainly containing CD86+ antitumoral M1 macrophages and CD206+ protumoral M2 macrophages. TAMs expression and density were assessed by immunohistochemical staining of CD68, CD86, and CD206 in tissue microarrays from 253 HCC patients. Clinicopathologic features and prognostic value of these markers were evaluated. We found that CD68+ TAMs were not associated with clinicopathologic characteristics and prognosis in HCC. Low presence of CD86+ TAMs and high presence of CD206+ TAMs were markedly correlated with aggressive tumor phenotypes, such as multiple tumor number and advanced tumor-node-metastasis (TNM) stage; and were associated with poor overall survival (OS) (p = 0.027 and p = 0.024, respectively) and increased time to recurrence (TTR) (p = 0.037 and p = 0.031, respectively). In addition, combined analysis of CD86 and CD206 provided a better indicator for OS (p = 0.011) and TTR (p = 0.024) in HCC than individual analysis of CD86 and CD206. Moreover, CD86+/CD206+ TAMs predictive model also had significant prognosis value in α-fetoprotein (AFP)-negative patients (OS: p = 0.002, TTR: p = 0.005). Thus, these results suggest that combined analysis of immune biomarkers CD86 and CD206 could be a promising HCC prognostic biomarker.

7 January 2021 in Journal of Hematology & Oncology
Verified
Journal Article
Open access
PDF file
YZYi Zhou
Yi Zhou
LHLiang Hu
Liang Hu
WTWenqing Tang
Wenqing Tang
DLDongping Li
Dongping Li
LMLijie Ma
Lijie Ma
SZSi Zhang
Si Zhang
Background: Key hepatic molecules linking gut dysbiosis and hepatocarcinogenesis remain largely unknown. Gut-derived gut microbiota contains pathogen-associated molecular patterns (PAMPs) that may circulate into the liver and, consequently, be recognized by hepatic pattern recognition receptors (PRRs). NOD2, a general intracellular PRR, recognizes muramyl dipeptide (MDP), present in both gram (+) and gram (−) bacteria. Here, we investigated the role of NOD2 as a molecular sensor translating gut dysbiosis signaling into hepatocarcinogenesis. Methods: NOD2 expression was measured in clinical hepatocellular carcinoma (HCC) samples using qPCR (80 pairs), western blotting (30 pairs) and immunostaining (141 pairs). The role of NOD2 in hepatocarcinogenesis was examined in the hepatocyte-specific Nod2-knockout (Nod2△hep), Rip2-knockout (Rip2△hep), Lamin A/C-knockout (Lamn△hep) and Rip2/Lamin A/C double-knockout (Rip2/Lamn△hep) mice models of diethylnitrosamine (DEN)/CCl4-induced HCC. Results: NOD2 was upregulated and activated in HCC samples, and high NOD2 expression correlated with poor prognosis in HCC patients. Hepatic NOD2 deletion in vivo decreased DEN/CCl4-induced HCC by reducing the inflammatory response, DNA damage and genomic instability. NOD2 activation increased liver inflammation via RIP2-dependent activation of the MAPK, NF-κB and STAT3 pathways. Notably, a novel RIP2-independent mechanism was discovered, whereby NOD2 activation induces the nuclear autophagy pathway. We showed that NOD2 undergoes nuclear transport and directly binds to a component of nuclear laminae, lamin A/C, to promote its protein degradation, leading to impaired DNA damage repair and increased genomic instability. Conclusions: We reveal a novel bridge, bacterial sensor NOD2, linking gut-derived microbial metabolites to hepatocarcinogenesis via induction of the inflammatory response and nuclear autophagy. Thus, we propose hepatic NOD2 as a promising therapeutic target against HCC.

8 May 2014 in FEBS Letters
Verified
Journal Article
Closed access
LJLingling Ji
Lingling Ji
RXRuyi Xue
Ruyi Xue
WTWenqing Tang
Wenqing Tang
WWWeibin Wu
Weibin Wu
THTingting Hu
Tingting Hu
SZSi Zhang
Si Zhang

1 July 2014 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
XLXijun Liu
Xijun Liu
RXRuyi Xue
Ruyi Xue
LJLingling Ji
Lingling Ji
XZXingwang Zhang
Xingwang Zhang
Jian WuJian Wu
Jian Wu
She ChenShe Chen
She Chen

9 February 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
XLXijun Liu
Xijun Liu
XZXingwang Zhang
Xingwang Zhang
LJLingling Ji
Lingling Ji
JGJianxin Gu
Jianxin Gu
MZMeiling Zhou
Meiling Zhou
She ChenShe Chen
She Chen
Farnesoid X receptor associates with -catenin and inhibits its activity in hepatocellular carcinoma Farnesoid X receptor associates with β-catenin and inhibits its activity in hepatocellular carcinoma

1 August 2018 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
XLXijun Liu
Xijun Liu
RXRuyi Xue
Ruyi Xue
CYCaiting Yang
Caiting Yang
JGJianxin Gu
Jianxin Gu
She ChenShe Chen
She Chen
SZSi Zhang
Si Zhang
The liver is the main site of estrogen metabolism, and liver disease is usually associated with an abnormal estrogen status. However, little is known about the mechanism underlying this connection. Here, we investigated the effects of bile acid (BA)-activated farnesoid X receptor (FXR) on the metabolism of 17β-estradiol (E2) during blockage of bile flow (cholestasis). Correlations between BA levels and E2 concentrations were established in patients with cholestasis, and hepatic expression profiles of key genes involved in estrogen metabolism were investigated in both WT and FXR−/− mice. We found that the elevated E2 level positively correlated with BA concentrations in the patients with cholestasis. We further observed that bile duct ligation (BDL) increases E2 levels in mouse serum, and this elevation effect was alleviated by deleting the FXR gene. Of note, FXR down-regulated the expression of hepatic sulfotransferase SULT1E1, the primary enzyme responsible for metabolic estrogen inactivation. At the molecular level, we found that FXR competes with the protein acetylase CREB-binding protein (CBP) for binding to the transcription factor hepatocyte nuclear factor 4α (HNF4α). This competition decreased HNF4α acetylation and nuclear retention, which, in turn, repressed HNF4α-dependent SULT1E1 gene transcription. These findings suggest that cholestasis induces BA-activated FXR activity, leading to downstream inhibition of SULT1E1 and hence impeding hepatic degradation of estrogen.